biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The vote

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jan 11, 2023 1:47pm

107 Views

Post# 35216333

RE:The vote

No one takes poof seriously. He's an absolute joke that continues to waste his time here. Even if there were those that listened to him, does it matter? Hardly anyone is here anymore. Look at the number of posters. Most already sold out and finally, finally moved on. There is nothing that the few here who actually own shares for some silly reason can do about the upcoming shareholder vote. It's done. The decision has been made by the board and it will pass. Game over.....as it has been for years

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide